AI assistant
Sending…
InspireMD, Inc. — Proxy Solicitation & Information Statement 2025
Apr 16, 2025
34187_rns_2025-04-16_de6ea2eb-429f-49c7-b641-72eb6346708f.zip
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
DEFA14A 1 formdefa14a.htm
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|---|
| ☐ | Confidential, for Use of the Commission Only (as |
| permitted by Rule 14a-6(e)(2)) | |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
INSPIREMD, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| Payment of
| Filing Fee (Check the appropriate box): | |
|---|---|
| ☒ | No fee required. |
| ☐ | Fee paid previously with |
| preliminary materials. | |
| ☐ | Fee computed on table in |
| exhibit required by Item 25(b) per Exchange Act Rules 14a–6(i)(1) and 0–11 |
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
Field: Page; Sequence: 2
Field: /Page
Field: Page; Sequence: 3; Options: Last
Field: /Page
More from InspireMD, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Board/Management Information
2026
May 22
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 20
Capital/Financing Update
2026
Apr 3
Capital/Financing Update
2026
Apr 3
Annual Report
2026
Mar 18
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11
Major Shareholding Notification
2026
Feb 2